[Autoimmune thyroid disease].
Hidaka
Yoh
Y
Department of Laboratory Medicine, Osaka University Graduate School of Medicine.
D000818:Animals; D013956:Antithyroid Agents / Q000627:therapeutic use; D017209:Apoptosis; D053222:Fas Ligand Protein; D006111:Graves Disease / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007375:Interleukin-1; D007453:Iodide Peroxidase / Q000276:immunology; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008562:Membrane Glycoproteins; D008713:Methimazole / Q000627:therapeutic use; D011379:Prognosis; D011989:Receptors, Thyrotropin / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D013954:Thyroglobulin / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D013974:Thyroxine / Q000627:therapeutic use
D013956:Antithyroid Agents; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D007074:Immunoglobulin G; D007375:Interleukin-1; D007457:Iodine Radioisotopes; D008562:Membrane Glycoproteins; D011989:Receptors, Thyrotropin; D008713:Methimazole; D013954:Thyroglobulin; D007453:Iodide Peroxidase; D013974:Thyroxine